Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Color Atlas and Synopsis of Pediatric Dermatology
Sandipan Dhar
1:
NEONATAL DERMATOSES
MONGOLIAN SPOT (Figures 1.1 and 1.1A)
Natural History
Management
NEONATAL ACNE (Figures 1.2 TO 1.4)
Management
NEONATAL MILIA (Figure 1.5)
Natural History
TOXIC ERYTHEMA OF THE NEWBORN (Figures 1.6 to 1.7A)
Differential Diagnosis
Diagnosis
Treatment
INTERTRIGO (Figure 1.8)
Management
MILIARIA (Figures 1.9 and 1.9A)
Differential Diagnosis
Management
STAPHYLOCOCCAL SCALDED SKIN SYNDROME (SSSS) (Figures 1.10 and 1.11)
Diagnosis
Prognosis
Management
SUCKLING BLISTER (Figure 1.12)
Differential Diagnosis
Treatment
NEONATAL HERPES SIMPLEX (Figures 1.13 to 1.15)
Diagnosis
Management
UMBILICAL POLYP (Figures 1.16 and 1.17)
Treatment
UMBILICAL GRANULOMA (Figure 1.18)
Treatment
CONGENITAL SYPHILIS (Figures 1.19 and 1.20)
Treatment
SUBCUTANEOUS FAT NECROSIS (Figures 1.20A and 1.20B)
Differential Diagnosis
Management
SCLEREMA NEONATORUM (Figures 1.21 and 1.22)
Prognosis
Management
HAIRY TRAGUS (Figure 1.23)
POLYTHELIA (SUPERNUMERARY NIPPLES) (Figure 1.24)
Treatment
PHYSIOLOGICAL EXFOLIATION OF NEWBORNS (Figure 1.25)
Treatment
CUTIS MARMORATA (Figures 1.26 and 1.26A)
Treatment
2:
VASCULAR, MELANOCYTIC AND OTHER NEVI
SALMON PATCH (Figures 2.1 and 2.1A)
Natural History
Management
HEMANGIOMA (Figures 2.2 to 2.6C)
Natural History
Management
KLIPPEL-TRENAUNAY SYNDROME (Figures 2.7 to 2.9)
Treatment
ANGIOKERATOMA CIRCUMSCRIPTUM (Figures 2.10 and 2.11)
Natural History
Treatment
LYMPHANGIOMA CIRCUMSCRIPTUM (Figures 2.12 to 2.14)
Treatment
NEVUS OF OTA AND ITO (Figures 2.15 and 2.16)
Management
MELANOCYTIC NEVUS (Figures 2.17 to 2.20C)
Natural History
Management
Systemic Associations
BECKER'S NEVUS (Figures 2.20D and 2.20E)
Etiology
Treatment
LENTIGENES (Figure 2.21)
Natural History
Treatment
LEOPARD SYNDROME (Figure 2.22)
FRECKLES (EPHELIDES) (Figures 2.22A and 2.22B)
Treatment
NEVUS SPILUS (Figures 2.22C, 2.22D and 2.22E)
PEUTZ – JEGHERS SYNDROME (Figures 2.23 to 2.26)
Management
EPIDERMAL NEVI (Figures 2.26A to 2.26F)
Treatment
INFLAMMATORY LINEAR VERRUCOUS EPIDERMAL NEVUS (ILVEN) (Figure 2.27)
Management
NEVUS SEBACEOUS (Figures 2.28 to 2.28B)
Systemic Associations
Treatment
NEVUS COMEDONICUS (Figure 2.29)
Natural History
Management
3:
GENODERMATOSES
ECTODERMAL DYSPLASIA (Figures 3.1 to 3.4)
Treatment
Management
XERODERMA PIGMENTOSUM (Figures 3.5 to 3.8)
Natural History
Treatment
PSEUDOXANTHOMA ELASTICUM (Figures 3.9 and 3.10)
Systemic Associations
Management
DARIER'S DISEASE (Figures 3.11 to 3.13)
Management
PROGERIA (Figures 3.14 to 3.18)
Prognosis
4:
DISORDERS OF KERATINIZATION
ICHTHYOSIS VULGARIS (Figures 4.1 and 4.2)
Natural History
Management
X-LINKED RECESSIVE ICHTHYOSIS (XLRI) (Figures 4.3 to 4.3B)
Systemic Associations
Natural History
Treatment
LAMELLAR ICHTHYOSIS (LI) (Figures 4.4 and 4.5)
Management
NONBULLOUS ICHTHYOSIFORM ERYTHRODERMA (NBIE) (Figures 4.6 to 4.9)
Management
EPIDERMOLYTIC HYPERKERATOSIS (BULLOUS ICHTHYOSIFORM ERYTHRODERMA) (Figures 4.10 to 4.13)
Differential Diagnosis
Management
COLLODION BABY (Figures 4.14 to 4.19)
Complications
Treatment
HARLEQUIN FETUS (Figure 4.20)
Natural History
Complications
Treatment
PITYRIASIS RUBRA PILARIS (Figures 4.21 to 4.24C)
Treatment
5:
INFECTIONS AND INFESTATIONS
SCABIES (Figures 5.1 to 5.3A)
Complications
Treatment
PEDICULOSIS (Figure 5.3B)
Pediculosis Capitis (Head Louse Infestation)
Pediculosis Corporis (Body Louse Infestation)
Pediculosis Pubis
FURUNCULOSIS (Figures 5.4 and 5.5)
IMPETIGO (Figures 5.6 to 5.8)
ECTHYMA (Figures 5.9 and 5.10)
CELLULITIS AND ERYSIPELAS (Figures 5.11 and 5.11A)
Complications
Treatment
ACUTE LYMPHANGIITIS (Figure 5.12)
Differential Diagnosis
SYCOSIS BARBAE (Figures 5.12A and 5.12B)
Etiology
Management
LUPUS VULGARIS (Figures 5.13 to 5.13C)
SCROFULODERMA (Figures 5.14A to C)
TUBERCULOSIS VERRUCOSA CUTIS (Figures 5.14D and E)
Treatment
LEPROSY
INDETERMINATE LEPROSY (Figure 5.15)
BORDERLINE TUBERCULOID LEPROSY (Figures 5.16 and 5.17A)
BORDERLINE LEPROMATOUS LEPROSY (Figure 5.17B)
Treatment
COMMON WARTS (VERRUCA VULGARIS) (Figures 5.18 and 5.19A TO D)
Natural History
Treatment
VERRUCA PLANA (Figures 5.19E and 5.19F)
Treatment
MOLLUSCUM CONTAGIOSUM (Figures 5.20 to 5.24)
Treatment
PITYRIASIS ROSEA (Figures 5.25 and 5.26)
Natural History
Treatment
HERPES SIMPLEX INFECTION (Figures 5.27 to 5.30)
Herpetic Gingivostomatitis
Herpes Genitalis
Keratoconjunctivitis
HERPES ZOSTER (Figures 5.31 to 5.33)
Treatment
TINEA CORPORIS AND TINEA FACIEI (Figures 5.34 to 5.40)
Management
TINEA PEDIS AND TINEA MANUM (Figures 5.40A to 5.40C)
Diagnosis
Treatment
PITYRIASIS VERSICOLOR (Figures 5.41 and 5.42)
Treatment
PARONYCHIA (Figures 5.43 and 5.44)
Treatment
6:
EXANTHEMS OF INFECTIVE ETIOLOGY
MEASLES (RUBEOLA) (Figures 6.1 to 6.3)
Prophylaxis
GERMAN MEASLES (RUBELLA) (Figures 6.4 and 6.5)
Prophylaxis
CONGENITAL RUBELLA (Figure 6.6)
Prophylaxis
VARICELLA (CHICKENPOX) (Figures 6.7 to 6.9)
Management
DENGUE FEVER (Figures 6.10 to 6.15)
Diagnosis
Management
GIANOTTI-CROSTI SYNDROME (Figures 6.15A to 6.15C)
Etiology
Treatment
STAPHYLOCOCCAL SCALDED SKIN SYNDROME (SSSS) (Figures 6.16 and 6.17)
Prognosis
Treatment
TOXIC SHOCK SYNDROME (Figure 6.18)
Treatment
HAND-FOOT-AND-MOUTH DISEASE (HFMD) (Figures 6.19 to 6.22)
7:
ECZEMA AND DERMATITIS
NAPKIN DERMATITIS (Figures 7.1 and 7.2)
Management
IRRITANT DERMATITIS (Figures 7.3 and 7.3A)
Treatment
LIPLICKER'S DERMATITIS (Figures 7.3B and 7.3C)
Treatment
CRADLE CAP (Figure 7.4)
Treatment
INFANTILE SEBORRHEIC DERMATITIS (Figures 7.5 to 7.7)
Differential Diagnosis
Treatment
PAPULAR URTICARIA (Figures 7.8 and 7.9)
Complication
Treatment
NODULAR PRURIGO (Figure 7.10)
Treatment
ATOPIC DERMATITIS (Figures 7.11 to 7.14, 7.28 to 7.34)
Clinical Features
INFANTILE PHASE (Figure 7.31)
CHILDHOOD PHASE (Figures 7.32 and 7.33)
ADULT PHASE (Figure 7.34)
ATOPIC HAND ECZEMA
PITYRIASIS ALBA (Figure 7.15)
KERATOSIS PILARIS (Figures 7.16 and 7.16A)
DENNIE-MORGAN FOLDS (Figure 7.17)
GEOGRAPHIC TONGUE (BENIGN MIGRATORY GLOSSITIS) (Figures 7.18A and 7.18B)
JUVENILE PLANTAR DERMATITIS (Figures 7.19 and 7.20)
POMPHOLYX (Figure 7.21)
SEVERE ATOPIC DERMATITIS (Figure 7.35)
Treatment
Topical Calcineurin Inhibitors
INFECTIOUS ECZEMATOID DERMATITIS (Figures 7.36 and 7.37)
Treatment
MILIARIAL ECZEMA (Figures 7.38 to 7.40)
Treatment
8:
PAPULOSQUAMOUS DISORDERS
CHILDHOOD PSORIASIS (Figures 8.1 to 8.9A)
INFANTILE AND JUVENILE PUSTULAR PSORIASIS (Figures 8.9B to 8.12)
Topical Treatment
Systemic Therapy
LICHEN PLANUS (Figures 8.13 to 8.16)
Association
Natural History
Treatment
LICHEN NITIDUS (Figures 8.17 and 8.18)
Natural History
Treatment
9:
VESICULOBULLOUS DISEASES
CHRONIC BULLOUS DERMATOSIS OF CHILDHOOD (CBDC) (Figures 9.1 to 9.4)
Natural History
Treatment
DERMATITIS HERPETIFORMIS (DH) (Figure 9.5)
Treatment
CICATRICIAL PEMPHIGOID (Figures 9.5A to 9.5D)
Diagnosis
Treatment
EPIDERMOLYSIS BULLOSA (EB) (Figures 9.6 to 9.16)
Management
PEMPHIGUS VULGARIS AND PEMPHIGUS FOLIACEUS (Figures 9.17 to 9.19)
Diagnosis
Treatment
10:
NEUROCUTANEOUS DISORDERS
TUBEROUS SCLEROSIS COMPLEX (TSC) (Figures 10.1 to 10.6)
Primary Features
Secondary Features
Tertiary Features
Angiofibroma
Periungual Fibromas
Shagreen Patch
Ash Leaf Macules
NEUROFIBROMATOSIS AND CAFÉ-AU-LAIT MACULES (Figures 10.7 to 10.8B)
Management
McCUNE ALBRIGHT SYNDROME (Figure 10.9)
INCONTINENTIA PIGMENTI (Figures 10.10 and 10.11)
Systemic Association
Treatment
HYPOMELANOSIS OF ITO (Figure 10.12)
Treatment
FAUN TAIL NAEVUS (Figure 10.13)
Treatment
11:
PIGMENTARY DISORDERS
VITILIGO (Figures 11.1A to 11.4B)
Prognosis
Differential Diagnosis
Treatment
HALO NEVUS (Figures 11.4C to 14.4E)
Treatment
NEVUS DEPIGMENTOSUS (Figures 11.5 to 11.6A)
Treatment
NEVUS ANEMICUS (Figure 11.7)
Treatment
LICHEN SCLEROSUS ET ATROPHICUS (LSA) (Figures 11.8 to 11.8B)
Diagnosis
Treatment
POST KALA-AZAR DERMAL LEISHMANIASIS (PKDL) (Figure 11.9)
Management
ALBINISM (Figures 11.10 to 11.13)
Complications
Management
LICHEN STRIATUS (Figures 11.14 and 11.14A)
Natural History
Differential Diagnosis
Treatment
POST-INFLAMMATORY HYPOPIGMENTATION (Figures 11.15 to 11.16A)
Natural History
Treatment
POST-INFLAMMATORY HYPERPIGMENTATION (Figures 11.17 to 11.17B)
Natural History
Treatment
HYPERPIGMENTATION DUE TO ADDISON'S DISEASE (Figures 11.18 to 11.20)
FAMILIAL HYPERPIGMENTATION OF TONGUE (Figures 11.20A to 11.20D)
Management
12:
NUTRITIONAL DEFICIENCY DISORDERS
ACRODERMATITIS ENTEROPATHICA (Figures 12.1 and 12.2)
Diagnosis
Treatment
KWASHIORKOR (Figures 12.3 and 12.4)
Natural History
Management
PHRYNODERMA (Figure 12.5)
Diagnosis
VITAMIN B2 (RIBOFLAVIN) DEFICIENCY (Figures 12.6 and 12.7)
VITAMIN B12 (CYANOCOBALAMIN) DEFICIENCY (Figures 12.8 to 12.10)
Diagnosis
Treatment
13:
URTICARIA, MAST CELL AND HISTIOCYTIC DISORDERS
URTICARIA (Figures 13.1 to 13.3)
DERMOGRAPHISM (Figure 13.4)
Management
MASTOCYTOSIS (Figures 13.4A to 13.7)
SOLITARY MASTOCYTOMA
Prognosis
Urticaria Pigmentosa
DIFFUSE CUTANEOUS MASTOCYTOSIS (Figures 13.8 and 13.9)
Diagnosis
Treatment
LANGERHANS CELL HISTIOCYTOSIS
LETTERER-SIWE DISEASE (Figures 13.10 to 13.12C)
Treatment
HAND-SCHÜLLER-CHRISTIAN DISEASE
EOSINOPHILIC GRANULOMA (Figure 13.13)
Natural History
Management
14:
METABOLIC DISORDERS
ALKAPTONURIA (Figures 14.1 and 14.2)
Treatment
XANTHOMA (Figures 14.3 to 14.5)
Differential Diagnosis
Treatment
JUVENILE XANTHOGRANULOMA (Figure 14.5A)
Natural History
Systemic Associations
Treatment
CONGENITAL ERYTHROPOIETIC PORPHYRIA (GUNTHER'S DISEASE) (Figures 14.6 to 14.9)
Prognosis
Treatment
FABRY'S DISEASE (Figure 14.10)
Systemic Associations
Treatment
FARBER'S DISEASE (Figure 14.11)
Diagnosis
Prognosis
Treatment
LESCH-NYHAN SYNDROME (Figures 14.12 and 14.13)
Management
15:
COLLAGEN VASCULAR DISEASES AND VASCULITIS
DISCOID LUPUS ERYTHEMATOSUS (DLE) (Figures 15.1 to 15.7)
Management
DERMATOMYOSITIS (Figures 15.8 to 15.12)
Management
PROGRESSIVE SYSTEMIC SCLEROSIS (Figures 15.12A to C)
Management
MORPHEA (Figures 15.12D to F)
Natural History
Treatment
Parry-Romberg Syndrome (Figures 15.12G and 15.12H)
NECROTIZING VASCULITIS (Figures 15.13 to 15.16)
LIVEDOID VASCULITIS (Figures 15.17 and 15.18)
Treatment
POLYARTERITIS NODOSA (Figures 15.19 to 15.21)
Natural History
Prognosis
Management
PITYRIASIS LICHENOIDES (Figures 15.21A and 15.21B)
Etiology
Clinical Features
Differential Diagnosis
Treatment
16:
DISEASES OF HAIR AND NAIL
ALOPECIA AREATA (Figures 16.1 to 16.4B)
Natural History
Treatment
PSEUDOPELADE (Figure 16.4C)
Treatment
SCARRING ALOPECIA (Figure 16.5)
Treatment
TRICHOTILLOMANIA (Figure 16.5A)
Management
SEBORRHOEIC ALOPECIA (Figure 16.6)
OCCIPITAL ALOPECIA (Figure 16.7)
WOOLY HAIR (Figure 16.8)
MONILETHRIX (BEADED HAIR) (Figure 16.9)
PIEBALDISM (Figures 16.10 and 16.10A)
Natural History
Treatment
PREMATURE CANITIES (PREMATURE GREYING) (Figures 16.11 and 16.12)
Management
PITYRIASIS AMIANTACEA (TINEA AMIANTACEA) (Figures 16.12A and 16.12B)
Treatment
HYPERTRICHOSIS (Figures 16.13 and 16.14)
Treatment
PUNCTATE LEUCONYCHIA (Figures 16.15 to 16.17)
TOTAL LEUCONYCHIA (Figure 16.18)
MUEHRCKE'S NAILS (Figure 16.19)
TWENTY NAIL DYSTROPHY (TND) (Figures 16.20 and 16.20A)
NAIL SHEDDING IN STEVENS-JOHNSON SYNDROME (Figures 16.21 and 16.22)
17:
ACNE, ROSACEA AND HIDRADENITIS SUPPURATIVA
ACNE VULGARIS (Figures 17.1 and 17.2)
Management
ACNEIFORM ERUPTIONS (Figures 17.3A and 17.3B)
Treatment
ACNE EXCOREE (Figures 17.4A and 17.4B)
ROSACEA (Figures 17.5 and 17.6)
Treatment
HIDRADENITIS SUPPURATIVA (Figures 17.7 and 17.8)
Treatment
PITYROSPORUM FOLLICULITIS (Figures 17.9 and 17.10)
Etiology
Treatment
Natural History
18:
ADVERSE DRUG ERUPTIONS
MACULOPAPULAR ERUPTIONS (Figure 18.1)
Differential Diagnosis
Drug Responsible
Treatment
FIXED DRUG ERUPTION (Figures 18.2 to 18.4)
Drug Responsible
Treatment
ERYTHEMA MULTIFORME (Figures 18.5 to 18.9)
STEVENS – JOHNSON SYNDROME (Figures 18.10 to 18.12)
Drug Responsible
TOXIC EPIDERMAL NECROLYSIS (LYELL'S SYNDROME) (Figures 18.13 to 18.14A)
Drug Responsible
Management
SERUM SICKNESS (Figure 18.15)
Treatment
19:
STRIAE AND SCARS
IDIOPATHIC STRIAE DISTENSAE (Figures 19.1 to 19.3)
Natural History
Treatment
KELOID (Figure 19.4)
Treatment
TOPICAL STEROID INDUCED CUTANEOUS ATROPHY (Figure 19.5)
20:
MISCELLANEOUS DERMATOSES
ACANTHOSIS NIGRICANS (Figures 20.1 and 20.2)
Benign Forms
Malignant Forms
Natural History
Treatment
DYSKERATOSIS CONGENITA (Figures 20.3 to 20.6)
Natural History
Treatment
WISKOTT-ALDRICH SYNDROME (Figures 20.7A to 20.8)
Management
ATAXIA TELANGIECTASIA (Figures 20.9 and 20.10)
INFANTILE DIGITAL FIBROMATOSIS (IDF) (Figures 20.11 to 20.14)
Natural History
Treatment
ERYTHEMA NODOSUM (Figure 20.15)
Etiology
Drugs Responsible
Treatment
FRICTIONAL LICHENOID DERMATITIS (FLD) (Figures 20.16 and 20.17)
Treatment
SWEET'S SYNDROME (Figure 20.18)
Treatment
PIGMENTED PURPURIC DERMATOSES (PPD) (Figure 20.19)
Treatment
PALMOPLANTAR HYPERHIDROSIS (Figures 20.20 and 20.21)
Treatment
MILIA (Figures 20.22 to 20.24)
Treatment
CHRONIC ARSENIC POISONING (Figures 20.25 to 20.28)
Etiology and Epidemiology
Clinical Features
Diagnosis
Differential Diagnoses
Treatment
FORDYCE'S SPOTS (Figures 20.29 and 20.30)
POLYMORPHOUS LIGHT ERUPTION (PMLE) (Figures 20.31 to 20.33)
SUGGESTED READING
INDEX
TOC
Index
×
Chapter Notes
Save
Clear